Handelsavisen
prelaunch
Companies Basic Materials 003042.SZ
00
003042.SZ Shenzhen Stock Exchange Agricultural Chemicals

Shandong Sino-Agri United Biotechnology Co Ltd

¥16,65
Open in Charts → Attach watcher ⌖
CNY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
-0,6 %
ROE
-0,8 %
Net margin
-2,0 %
Debt / equity
0,81
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Shandong Sino-Agri United Biotechnology Co Ltd is a Chinese company engaged in the production and sale of agricultural chemicals, primarily serving the agricultural sector in China.

Business. Shandong Sino-Agri United Biotechnology Co Ltd (003042.SZ) is a Chinese company operating in the agricultural chemicals industry within the broader chemicals sector. The firm is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustryAgricultural Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-0,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 003042.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 003042.SZ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    Briefing · model-assisted

    Shandong Sino-Agri United Biotechnology Co Ltd (003042.SZ) has been formally classified within the Chemicals activity and Basic Materials economic sector, marking a significant structural update to its corporate profile. This taxonomy shift, identified as a medium-severity change, clarifies the company's operational positioning within the broader industrial landscape, moving from an undefined status to a specific sectoral alignment. Concurrently, the company’s risk assessment framework has been initialized with two new key metrics. Dilution risk is now rated as low, indicating a stable capital structure with minimal threat of share value erosion from new issuances. This assessment provides investors with a clearer baseline for evaluating equity stability, a critical factor for long-term holding strategies. In contrast, liquidity risk has been established at a medium level. This designation suggests that while the company maintains operational viability, there may be moderate constraints on the ease of trading its shares or accessing immediate cash resources. This medium-severity signal warrants attention for traders and liquidity-focused investors who prioritize ease of entry and exit. These updates collectively enhance the transparency of Shandong Sino-Agri United’s financial and operational profile. By defining its sectoral identity and quantifying key risks such as dilution and liquidity, the company offers a more robust foundation for fundamental analysis, despite the current absence of analyst coverage or index membership data in the available records.

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Shandong Sino-Agri United Biotechnology Co Ltd (003042.SZ) is a Chinese company operating in the agricultural chemicals industry within the broader chemicals sector. The firm is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorBasic Materials
    Business sectorChemicals
    IndustryAgricultural Chemicals
    ActivityChemicals
    AI synthesis
    GENERATED

    Shandong Sino-Agri United Biotechnology Co Ltd has a debt-to-equity ratio of 0.81, indicating a moderate level of leverage, while its current ratio of 0.84 suggests potential liquidity constraints, as current assets fall short of current liabilities. The company reported negative operating cash flow of -71.57 million CNY, which, combined with a net cash position that is negative after subtracting total debt, signals liquidity risk.

    Profitability metrics are weak, with a return on equity of -0.76% and a return on assets of -0.29%, both significantly below the industry median for Agricultural Chemicals. The company reported a net loss of 11.04 million CNY and an operating loss of 3.11 million CNY, indicating a failure to generate positive returns from operations.

    The company operates as a single business segment, with all revenue derived from agricultural chemicals. There is no geographic diversification disclosed, and the company is entirely exposed to the Chinese market. This concentration increases vulnerability to local economic and regulatory shifts.

    The company’s revenue for the latest period was 550.66 million CNY, but there is no disclosed growth trajectory or outlook for the next fiscal year. The absence of capital expenditure growth and the negative operating cash flow suggest a lack of investment in future capacity or expansion.

    The company faces medium liquidity risk due to negative operating cash flow and a current ratio below 1. While dilution risk is currently low, the company’s negative net income and operating cash flow could pressure future capital structure decisions. No recent equity issuance or dilutive events are disclosed in the latest financials.

    No recent filings or transcripts are available in the provided data to inform on strategic shifts, new product launches, or regulatory developments. The company’s financial performance and operational strategy remain opaque beyond the disclosed financials.

    Shandong Sino-Agri United Biotechnology Co Ltd (003042.SZ) has been formally classified within the Chemicals activity and Basic Materials economic sector, marking a significant structural update to its corporate profile. This taxonomy shift, identified as a medium-severity change, clarifies the company's operational positioning within the broader industrial landscape, moving from an undefined status to a specific sectoral alignment. Concurrently, the company’s risk assessment framework has been initialized with two new key metrics. Dilution risk is now rated as low, indicating a stable capital structure with minimal threat of share value erosion from new issuances. This assessment provides investors with a clearer baseline for evaluating equity stability, a critical factor for long-term holding strategies. In contrast, liquidity risk has been established at a medium level. This designation suggests that while the company maintains operational viability, there may be moderate constraints on the ease of trading its shares or accessing immediate cash resources. This medium-severity signal warrants attention for traders and liquidity-focused investors who prioritize ease of entry and exit. These updates collectively enhance the transparency of Shandong Sino-Agri United’s financial and operational profile. By defining its sectoral identity and quantifying key risks such as dilution and liquidity, the company offers a more robust foundation for fundamental analysis, despite the current absence of analyst coverage or index membership data in the available records.

    Key takeaways
    • The company is operating at a loss, with negative returns on equity and assets.
    • Liquidity is constrained, with a current ratio below 1 and negative operating cash flow.
    • The company is entirely exposed to the Chinese market, with no geographic diversification.
    • There is no disclosed growth in capital expenditure or revenue, suggesting limited investment in future capacity.
    • Dilution risk is currently low, but financial performance could pressure capital structure decisions in the future.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Free cash flow improved by 53.8% year-over-year, indicating significant operational efficiency gains despite recent revenue declines.

    Cash conversion ratio of 6.48 ranks best-in-class among 143 agricultural chemical peers, highlighting superior cash generation capabilities.

    Long-term debt decreased to 1.33 billion CNY from 1.28 billion CNY four years ago, showing a consistent deleveraging trend.

    Debt-to-equity ratio of 0.81 is below the cohort median of 0.34, suggesting a relatively conservative capital structure.

    Gross profit reached 185.4 million CNY in the latest period, maintaining positive gross margins despite net losses.

    BEAR CASE · 2

    Return on equity of -0.76% significantly underperforms the cohort median of 5.24%, indicating poor capital efficiency.

    The company faces high credit risk, signaling potential difficulties in meeting financial obligations or securing favorable financing.

    In focus — financials by report

    Valuation FY

    Market price
    ¥16,65
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    ¥1.44B
    Net cash
    -¥1.17B
    Current ratio
    0.8
    Debt / equity
    0.8
    ROA
    -0.3%
    ROE
    -0.8%
    Cash conversion
    648.0%
    CapEx / revenue
    -0.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-0,6 %Bottom quartile
    Net Margin-2,0 %Bottom quartile
    ROE-0,8 %Bottom quartile
    Capex / Rev-0,7 %Above P75
    D/E0,81Below median
    Cash Conv6,48Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Shandong Sino-Agri United Biotechnology Co Ltd Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    003042.SZCanonical
    Shenzhen Stock Exchange · CNY

    Intel & risk

    What changed

    4 tracked-field change(s) detected vs prior analysis; max severity: medium.

    • Dilution risk— → lowlow
    • Liquidity risk— → mediumlow
    • Activity— → Chemicalsmedium
    • Economic sector— → Basic Materialsmedium
    vs prior analysis today
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage